Misonix hits back at Chinese distributor over FCPA contract dispute

Roger Hamilton-Martin

22 May 2017

A doctor holds an ultrasound medical device. iStock.com/zilli

Misonix, a US medical device manufacturer, has defended its decision to terminate the contract of a Chinese distributor after discovering possible foreign bribery violations.

Subscribe to Global Investigations Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.

Subscribe now

Already have access? Login below

Roger Hamilton-Martin

View full biography

Author

Unlock unlimited access to all Global Investigations Review content